Protection against multiple subtypes of influenza viruses by virus-like particle vaccines based on a hemagglutinin conserved epitope

BioMed Research International
Shaoheng ChenZe Chen

Abstract

We selected the conserved sequence in the stalk region of influenza virus hemagglutinin (HA) trimmer, the long alpha helix (LAH), as the vaccine candidate sequence, and inserted it into the major immunodominant region (MIR) of hepatitis B virus core protein (HBc), and, by using the E. coli expression system, we prepared a recombinant protein vaccine LAH-HBc in the form of virus-like particles (VLP). Intranasal immunization of mice with this LAH-HBc VLP plus cholera toxin B subunit with 0.2% of cholera toxin (CTB(*)) adjuvant could effectively elicit humoral and cellular immune responses and protect mice against a lethal challenge of homologous influenza viruses (A/Puerto Rico/8/1934 (PR8) (H1N1)). In addition, passage of the immune sera containing specific antibodies to naïve mice rendered them resistant against a lethal homologous challenge. Immunization with LAH-HBc VLP vaccine plus CTB(*) adjuvant could also fully protect mice against a lethal challenge of the 2009 pandemic H1N1 influenza virus or the avian H9N2 virus and could partially protect mice against a lethal challenge of the avian H5N1 influenza virus. This study demonstrated that the LAH-HBc VLP vaccine based on a conserved sequence of the HA trimmer stalk region i...Continue Reading

References

Feb 1, 1987·The Journal of General Virology·D C WraithB A Askonas
Aug 18, 2001·Intervirology·P Pumpens, E Grens
May 28, 2005·Journal of Virology·Elisabetta BianchiAntonello Pessi
Nov 8, 2005·Journal of Clinical Microbiology·K M ButtYi Guan
Jan 18, 2008·The New England Journal of Medicine·UNKNOWN Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian InfTimothy M Uyeki
Feb 24, 2009·Nature Structural & Molecular Biology·Jianhua SuiWayne A Marasco
Mar 3, 2009·Science·Damian C EkiertIan A Wilson
May 9, 2009·The New England Journal of Medicine·Fatimah S DawoodTimothy M Uyeki
Jul 1, 2009·The New England Journal of Medicine·Gerardo ChowellMark A Miller
Jul 10, 2010·Proceedings of the National Academy of Sciences of the United States of America·Gayathri BommakantiRaghavan Varadarajan
Nov 19, 2010·The New England Journal of Medicine·Linda C Lambert, Anthony S Fauci
Aug 11, 2012·Science·Cyrille DreyfusRobert H E Friesen
Oct 17, 2013·PLoS Pathogens·Suxiang TongRuben O Donis

❮ Previous
Next ❯

Citations

Mar 20, 2016·Current Opinion in Biotechnology·Andrew B HillCharles H Jones
Jan 20, 2016·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Karin L LeeNicole F Steinmetz
Mar 2, 2016·Current Opinion in Virology·Florian Krammer
Aug 6, 2019·Frontiers in Immunology·Cynthia Calzas, Christophe Chevalier
Apr 4, 2021·Vaccines·Brianna L Bullard, Eric A Weaver
Aug 8, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Lorena Zapata-CuellarAbel Gutiérrez-Ortega

❮ Previous
Next ❯

Datasets Mentioned

BETA
CY009444.1
FJ384759.1
EF541402.1
AF100309.1

Methods Mentioned

BETA
ELISA
lavage
phage display

Software Mentioned

GraphPad Prism

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.